Swiss National Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,086,400
| Closed | -$963K | – | 2701 |
|
|
2022
Q4 | $963K | Buy |
1,086,400
+164,100
| +18% | +$145K | ﹤0.01% | 2367 |
|
|
2022
Q3 | $1.45M | Buy |
922,300
+218,300
| +31% | +$343K | ﹤0.01% | 2096 |
|
|
2022
Q2 | $1.42M | Buy |
704,000
+15,900
| +2% | +$32K | ﹤0.01% | 2156 |
|
|
2022
Q1 | $1.6M | Buy |
688,100
+64,900
| +10% | +$151K | ﹤0.01% | 2160 |
|
|
2021
Q4 | $2.9M | Buy |
623,200
+19,900
| +3% | +$92.5K | ﹤0.01% | 1811 |
|
|
2021
Q3 | $4.6M | Buy |
603,300
+16,300
| +3% | +$124K | ﹤0.01% | 1518 |
|
|
2021
Q2 | $5.69M | Buy |
587,000
+76,400
| +15% | +$740K | ﹤0.01% | 1415 |
|
|
2021
Q1 | $4.22M | Buy |
510,600
+20,400
| +4% | +$169K | ﹤0.01% | 1564 |
|
|
2020
Q4 | $3.35M | Buy |
490,200
+192,400
| +65% | +$1.31M | ﹤0.01% | 1612 |
|
|
2020
Q3 | $3.32M | Buy |
297,800
+34,600
| +13% | +$386K | ﹤0.01% | 1433 |
|
|
2020
Q2 | $1.65M | Buy |
+263,200
| New | +$1.65M | ﹤0.01% | 1821 |
|
|
2019
Q4 | – | Sell |
-178,300
| Closed | -$382K | – | 2552 |
|
|
2019
Q3 | $382K | Hold |
178,300
| – | – | ﹤0.01% | 2421 |
|
|
2019
Q2 | $476K | Hold |
178,300
| – | – | ﹤0.01% | 2426 |
|
|
2019
Q1 | $847K | Buy |
178,300
+13,200
| +8% | +$62.7K | ﹤0.01% | 2155 |
|
|
2018
Q4 | $396K | Buy |
165,100
+46,200
| +39% | +$111K | ﹤0.01% | 2425 |
|
|
2018
Q3 | $523K | Hold |
118,900
| – | – | ﹤0.01% | 2400 |
|
|
2018
Q2 | $856K | Buy |
+118,900
| New | +$856K | ﹤0.01% | 2256 |
|
|
2017
Q2 | – | Sell |
-75,764
| Closed | -$299K | – | 2575 |
|
|
2017
Q1 | $299K | Hold |
75,764
| – | – | ﹤0.01% | 2487 |
|
|
2016
Q4 | $371K | Buy |
+75,764
| New | +$371K | ﹤0.01% | 2483 |
|